ABSTRACT: The Na + -Ca 2+ exchanger in mammalian heart muscle (NCX1) is the central transporter protein that regulates extrusion of Ca 2+ from the heart cell. However, the functional biochemistry and physiology of NCX1 have been severely hampered by the absence of any specific high-affinity inhibitor. Here we describe advanced procedures for purifying a candidate inhibitor, previously called endogenous inhibitor factor (NCX IF ), and demonstrate its direct actions on NCX1 activities in the single-cell system. A combination of advanced HILIC (hydrophilic interaction liquid chromatography) procedures with analytical tests suggests that the properties of NCX IF resemble those of a small (disaccharide size) polar molecule lacking any aromatic rings, conjugated bonds, or a primary amino group.
Proteins of the NCX gene family contribute to Ca 2+ regulation in many cell types (1) (2) (3) (4) , with three genes responsible for expression, namely, NCX1, NCX2, and NCX3, with multiple splice variants (2, (5) (6) (7) . In heart, the electrogenic Na + -Ca 2+ exchange (8) is due to the gene product of NCX1.1, and although the molecular and biophysical properties have been broadly studied (2-7), endogenous regulation is incompletely understood (9) (10) (11) (12) (13) . Nevertheless, it is clear that changes in NCX1 protein expression accompany the development of diverse diseases such as heart failure and arrhythmia (2) (3) (4) 9) . There is, however, considerable uncertainty regarding the role played by NCX1 in these diseases; moreover, to date, there is no evidence that the NCX1 activity is the primary cause of such diseases, nor are mutations of NCX1 linked to any specific disease. Nevertheless, NCX1 protein levels may change and certainly contribute to Ca 2+ transport and signaling dysfunction, although the details remain poorly understood (2) (3) (4) 9) .
The Na + -Ca 2+ exchange turnover rate is clearly affected by the intracellular Ca 2+ , Na + , and H + ions, which interact with the regulatory cytosolic f-loop of NCX proteins (3, 4, (10) (11) (12) (13) . Other cellular factors (ATP, PIP 2 , and lipids) also can modulate NCX1, but their physiological relevance is still unclear (11, 12) . No phosphorylation of the cardiac NCX1 protein has been demonstrated either in vitro or in vivo. Recent breakthroughs in elucidating the three-dimensional structure revealed that the f-loop contains two Ca 2+ -binding domains, CBD1 and CBD2 (14) (15) (16) , which may modulate the NCX1 activity by sensing the cytosolic Ca 2+ concentrations. If specific endogenous factors exist, affecting the Ca 2+ interactions with the cytosolic regulatory domains, they may be quite important.
We isolated (from calf ventricle extracts) and purified a low-molecular mass substance that inhibits NCX1 in sarcolemma vesicles (17, 18) . Mass spectroscopic and gel filtration analyses of active fractions revealed a small (350-550 Da) polar molecule that is not retained on the regular RP-HPLC columns (17, 18) . Chemical tests and spectroscopic analyses showed no content for conjugated bonds, aromatic rings, primary amines, or aldehyde groups, the properties thereby resembling those of nonreducing "sugarlike" molecules (17, 18) . This low-abundance compound inhibits NCX1 activities in the range of 10 -6 -10 -7 M (18), but it has no effect on the Na + /K + -ATPase or SR Ca 2+ -ATPase activities (19) . This compound was termed "the NCX inhibitory factor" (NCX IF ).
Application of NCX IF to organ bath solutions elevates the contractility of ventricle strips (17, 20) , meaning that NCX IF could be a physiologically active substance. Importantly, the 1 -blocker (deraline) does not affect these actions (20) , suggesting that NCX IF may act through a mechanism that is independent of the -adrenergic pathway. Moreover, NCX IF could suppress ouabain-induced arrhythmias, the properties thereby resembling those of antiarrhythmic agents (23) . This suppression of arrhythmia may represent the NCX IF (20, 22) . To test the sidedness of the action of NCX IF , we directly loaded purified NCX IF into the cytoplasm through the patch-clamp electrode and examined the action of NCX IF on I NCX and Ca 2+ extrusion. We provide strong evidence that NCX IF blocks NCX1 from the inside of the cell with great efficacy, meaning that NCX IF may be an endogenous regulator of Ca 2+ transport through the regulation of NCX1 in intact cells.
MATERIALS AND METHODS

Materials and Reagents.
Protease inhibitors (PMSF, pepstatin, leupeptin, and aprotenin), deoxyribonuclease I (type DN-25), fluorescamine, 1 Dowex-50W 1X8, Dowex-AG 1X4, and laminin were obtained from Sigma (St. Louis, MO). Sephadex G-10 (fine) was from Pharmacia (Uppsala, Sweden). The glass microfiber filters (GF/C Whatman) were purchased from Tamar (Jerusalem, Israel). Chelex 100 was obtained from Bio-Rad. 45 CaCl 2 (10-30 mCi/mg) was purchased from DuPont NEN (Boston, MA) or Perkin-Elmer (Monza, Italy). Fluo-4 (K 5 ) and Fluo-3 AM were from Teflabs (Austin, TX), Biotium (Toronto, ON), or Molecular Probes (Eugene, OR). The following reagents were used for preparing cardiomyocytes: penicillin streptomycin (Biological Industries, Haemek, Israel), bovine calf serum (Hyclone), collagenase II (Worthington), and trypsin, minimal essential medium-1, and L-glutamine (Gibco Invitrogen). The scintillation cocktail Opti-Fluor was from Packard (Groningen, The Netherlands). All other reagents were analytical or HPLC grade. Deionized water (18 MΩ/cm, Millipore system) was used for preparing solutions. 45 Ca Uptake in Sarcolemma Vesicles. The sarcolemma vesicles were obtained according to established procedures (27, 28) . The Na idependent 45 Ca uptake was initiated by rapid dilution of Naloaded vesicles in an assay medium containing 45 Ca with lipid/protein-free aliquots of NCX IF (17) (18) (19) (20) (21) (17) (18) (19) (20) (21) (22) (23) . Briefly, after ethanol was evaporated, the remaining aqueous phase was reduced to 0.3-0.5 L and insoluble material was removed by centrifugation (20000g for 30 min). From the supernatant, lipids were removed with chloroform, and cold ethanol (-20°C ) was added to the aqueous phase (to yield ∼80%). White precipitate was removed by centrifugation, and after ethanol was evaporated, cold acetone was added to yield ∼90%. White precipitate was removed by centrifugation, and concentrated material (100-150 mL) was passed through equal volumes of Dowex 2X8 (acetate form) and Dowex 50W (H + form) slurry. The collected effluents were reduced to 50-80 mL (yellow-brown color) and then passed through the CarbPacking SPE (60 mL/10 g) cartridge (Supelco, Bellefonte, PA). The nearly colorless effluent (30-50 mL) was loaded onto the Sephadex G-10 column (5.5 cm × 70 cm) and flushed with water (2 mL/min). The fractions containing the NCX IF activity were concentrated, filtered, and stored at -70°C until they were purified further (17, 18) .
Effect of NCX IF on Na i -Dependent
Chromatography. Fully computerized HPLC systems were used for NCX IF purification, as described in previous publications (18) (19) (20) (21) (22) (23) Preparation of Cardiomyocytes. Isolated ventricular myocytes were obtained from adult female Sprague-Dawley rats (225-250 g). Briefly, rats were deeply anesthetized with sodium pentobarbital (0.1 mg/g ip) and heparinized (1.25 units/g ip). Fifteen minutes after heparin was injected, the heart was rapidly excised and rinsed with cold 250 µM EGTA isolation buffer containing 130 mM NaCl, 1 mM lactic acid, 5.4 mM KCl, 3 mM sodium pyruvate, 25 mM HEPES, 0.5 mM MgCl 2 , 0.33 mM NaH 2 PO 4 , 22 mM D-glucose, and 0.01 unit/mL insulin (pH 7.4) (adjusted with NaOH). The aorta was quickly cannulated for Langendorff perfusion. The heart coronary arteries were perfused at 37°C for 2 min with EGTA isolation buffer and then perfused for 8 min with the same buffer supplemented with 50 µM CaCl 2 , 1.6 mg/mL collagenase (type II; Worthington Biochemical, Lakewood, NJ), and 0.04 mg/mL protease (XIV). The ventricles were cut down, minced, and then gently agitated for 4 min in isolation buffer containing 83 µM CaCl 2 , 1 mg/mL collagenase, 0.066 mg/mL protease, and 1.66% BSA. The cells were filtered through nylon mesh (300 µm) and, after being washed, were resuspended, in succession, in enzyme-free isolation buffer (1% BSA) containing 250 and 500 µM CaCl 2 . After a final wash, the cardiomyocytes were resuspended at room temperature in the cell medium (17.4 mg/mL HEPES-buffered DMEM) supplemented with 10% fetal calf serum (Gibco), 0.01 unit/mL insulin, and 44 mM NaCl (pH 7.4) (adjusted with NaOH).
Simultaneous Measurements of I NCX and [Ca] i by PatchClamp and Confocal Microscopy.
A patch-clamp method was combined with confocal Ca 2+ imaging microscopy to enable simultaneous measurement of I NCX and [Ca] i recordings in single cardiomyocytes exposed to a submaximal but high level (5 mM) of caffeine (24) (25) (26) . To this end, freshly isolated cardiomyocytes were attached to laminin-coated coverslips and used within 4-5 h. Only quiescent, rodshaped myocytes with clear striations were used. Experiments were performed at room temperature (20-23°C). The GigaOhm seal was attained while superfusing the recording chamber with normal Tyrode containing 140 mM NaCl, 10 mM D-glucose, 2 mM CaCl 2 , 10 mM HEPES, 1 mM MgCl 2 , and 4 mM KCl (pH 7.4) (adjusted with NaOH). The patch pipet (1.8-2.2 MΩ) was filled with a solution that contained 2.5 mM Na 2 ATP, 2.5 mM MgATP, 2.5 mM MgCl 2 , 30 mM KCl, 110 mM potassium aspartic acid, 10 mM HEPES, 0.05 mM Fluo-4 (K 5 ) (Molecular Probes) (pH 7.2) (adjusted with KOH). After the whole-cell patch clamp was established, the cells were superfused with normal Tyrode supplemented with 5 mM 4-aminopyridine and 0.1 mM BaCl 2 . Cells were loaded for 8-10 min with Fluo-4 through the patch pipet before the experiments were started. Voltage control and recordings were performed with an Axopatch 200A amplifier and Digidata 1322A (Axon Instruments). Currents were lowpass filtered at 1 kHz and sampled at 2 kHz. All currents were normalized to cell capacitance to account for differences in cell size, and data are reported as current densities (picoamperes per picofarad). Cell capacitance was calculated from the capacity transient elicited by 10 ms hyperpolarization pulses from -90 to -95 mV. To elicit I NCX , the patched cardiomyocyte was held at -80 mV, and 5 mM caffeine was locally applied for 5 s by a Pneumatic Pico Pump (PV830, World Precision Instruments, Inc.).
[Ca] i imaging was performed with a Zeiss (LSM510) laser scanning confocal microscope equipped with an argon laser and a 63× 1.4 NA oil immersion objective (Zeiss). The scanned line was positioned along the longitudinal axis of the cardiomyocyte; Fluo-4 was excited at 488 nm, and the fluorescence above 505 nm was recorded. Line-scan images (time vs x) were acquired at a sampling rate of 1.92 ms/line. Caffeine application was repeated every 7 min for as long as the cardiomyocytes remained quiescent; the leak currents were stable and <200 pA. To keep the cardiomyocytes undamaged due to the caffeine exposure, 5 mM caffeine was used in all experiments.
Detection of the Ca 2+ Entry and Ca
2+ Exit Modes of NCX1 in Single Cardiomyocytes. The forward and reverse modes of NCX1 were measured in Fluo-3-loaded rat cardiomyocytes, according to established protocols (33, 34) . In these experiments, the SR function was completely blocked by pretreatment of cardiomyocytes with 10 µM ryanodine and 1 µM thapsigargin. To assess the Ca 2+ entry via NCX1, we abruptly replaced the extracellular NaCl (137 mM) with the same concentration of TMA for 20 s. The Ca 2+ exit mode was induced by replacing 137 mM TMA with 137 mM NaCl. The [Ca 2+ ] i in cardiomyocytes was detected with Fluo-3 by using wide-field fluorescence microscopy (22) . The prepared coverslips, containing Fluo-3-loaded cardiomyocytes, were placed in a recording chamber on the stage of an inverted microscope (Olympus IX-71). The chamber was perfused with the following: 137 mM NaCl, 4 mM KCl, 1.2 mM MgSO 4 , 10 mM glucose, 10 mM HEPES, and 1.5 mM CaCl 2 (pH 7.4) at 27°C with a temperature controller system (Automatic Temperature Controller, TC-324B, Warner). The excitation light (mercury burner, 100 W, Osram) was passed through a set of neutral density and excitation filters (HQ480, Chroma) and focused with a 40× objective (LCPlanF1, Olympus) and field diaphragm (allowing full illumination of single cardiomyocytes). Next, the emitted fluorescence was filtered through the dichroic mirror (Q505LP, Chroma) and emission filter (HQ535, Chroma). The fluorescence signal was recorded with a photon counting device (C&L Instruments) and digitized with a PCI-DAQ card. Each experiment was recorded and stored as a separate file by using Chart version 4.12 (ADInstruments). After subtraction of autofluorescence, the Fluo-3-recorded signal was calibrated to [Ca] i values according to a pseudoratio equation. It was assumed that the K d value for Fluo-3 was 650 nM at 27°C and that the resting [Ca] i was 100 nM, before the cells were treated with thapsigargin and ryanodine.
Fluo-4 Calibration. In the confocal microscopy experiments, the average fluorescence per pixel in a scanned line was taken as the observed fluorescence. Before a cardiomyocyte was patched, its autofluorescence was measured under the same scanning conditions as in the following experiment. The F value was taken after subtracting the autofluorescence. Since the emission of Fluo-4 is negligible in the absence of Ca (F min ∼ 0), the [Ca 2+ ] i was calculated as K d (F)/(F max -F). F max was measured directly from each cardiomyocyte at the end of the experiment, as previously outlined (24, 25) .
Miscellaneous Assays. The amount of protein was measured by using a modified method of Lowry (35) . Fluorescamine was used for detecting the R-amines and peptides (36) . Reducing sugars were detected with phenol-sulfuric acid reagent (37) . All analytical assays were downscaled for microplate measurements.
Statistics. All data are presented as means ( the standard error of the mean (SEM). Statistical analysis was done by using the Two-Sample t-Test (Origin 7.0). P values of <0.05 were considered to be significant.
RESULTS
HPLC Procedures for NCX IF Purification.
The previous purification procedures of NCX IF suffered from inadequate pure separation quality, low loading capacity, and unsatisfactory levels of final yield (17, 18) . A new set of advanced HILIC columns was introduced to overcome these problems. The new purification scheme is based on combining new preparative (Krumasil-Silica) and analytic (ZIC-HILIC and apHera) HILIC columns with previously explored preparative columns (RP Synergi-Polar and TSK-Amide 80) (Figure 1) . The new purification scheme provides a final yield of ∼0.03 mg of NCX IF /kg of starting material, which is at least 3-4 times higher than the highest yields obtained in previous preparations (17-23). A major reason for this improvement is the efficacy of the new HILIC columns, Krumasil-Silica ( Figure 1B) , ZIC-HILIC ( Figure 1D ), and apHera ( Figure  1E ). Despite this progress, currently available quantities of purified NCX IF are still not enough for structural studies by two-dimensional NMR.
The Aminex column is an excellent matrix for separating disaccharide, hexose, and pentose structures. Therefore, an attempt was made to compare the retention time of purified NCX IF to those of known molecular "witnesses" to find any possible correlation between the chromatographic behavior of NCX IF and its chemical structure. The inhibitory activity of NCX IF is eluted as a single peak while showing a complete ZIC-HILIC (0.5 mL/min), (E) apHera (1.0 mL/min), and (F) Cyclobond (1 mL/min). All other chromatographic conditions are described in Materials and Methods. Aliquots were removed from collected fractions, lyophilized, and then assayed for inhibition of the Na + -Ca 2+ exchanger by using the standard assay of Na i -dependent 45 Ca uptake in sarcolemma vesicles (see Materials and Methods). The active fractions obtained from 20-50 injections were pooled and lyophilized, and then the concentrated fractions were injected into the next column. Bars indicate the fractions containing the inhibitory activity of NCX IF . Next, the fractions were tested for inhibitory activity of the Na + -Ca 2+ exchanger by using the standard assay of Na + idependent 45 Ca uptake in isolated sarcolemma vesicles (see Materials and Methods). In control samples, the Na + -Ca Figure 1D ) and Aminex (Figure 2 ) columns is characteristic of disaccharide-sized molecules. Attempts at structural FIGURE 3: NCX IF -dependent inhibition of Ca 2+ entry and Ca 2+ exit modes of the Na + -Ca 2+ exchanger in intact cardiomyocytes. The Ca 2+ entry and Ca 2+ exit modes of NCX were monitored in intact cardiomyocytes by perfusing the recording chamber with 0 mM Na + medium for 20 s (abrupt-0Na). Then the chamber was perfused with normal medium, as indicated, and subsequently, the second session of the Ca 2+ entry and Ca 2+ exit reaction was generated in the same cardiomyocyte by switching to the 0 mM Na + perfusion medium for 20 s. Figure 3A) . Therefore, the inhibitory effects of NCX IF can be reliably evaluated in the same cardiomyocyte during the second Na + -abrupt episode (the first Na + -abrupt episode can be used as a control). The bidirectional Ca 2+ fluxes through NCX1 were examined by transient superfusion of cadiomyocytes with extracellular NCX IF (50 units/mL for 5 min). NCX IF significantly reduced the rate and magnitude of the changes in [Ca 2+ ] i ( Figure 3B ). NCX IF results in a slowing of the rate of Ca 2+ entry and of Ca 2+ exit ( Figure 3C ). Moreover, NCX IF reduces the amplitude of [Ca 2+ ] i elevation (to 15.0 ( 4.8% of the control; p < 0.001) and decreases the rate of Ca 2+ entry (11.9 ( 7.2% of the control; p < 0.001) and of Ca 2+ exit (5.6 ( 2.2% of the control; p < 0.0001) ( Figure 3D ). Therefore, NCX IF can effectively inhibit both the Ca 2+ entry and Ca 2+ exit modes of NCX1 in intact cardiomyocytes, as expected, on the basis of transport thermodynamics (50, 51) . These properties of NCX IF , which can comparably alter both the Ca 2+ entry and Ca 2+ exit modes of NCX1, seem to be very different from the properties of the synthetic NCX blocker, KB-R7943, which exhibits a preferential selectivity for inhibiting the Ca 2+ entry mode in a single-cardiomyocyte system (33, 38) .
Although the Na + -abrupt protocol enables us to assess the Ca 2+ entry and Ca 2+ exit modes of NCX1 in a single intact cell, this method cannot resolve whether NCX IF interacts with the extracellular or intracellular domain. Therefore, the application of complementary approaches was necessary to resolve the sidedness of NCX IF action in intact cardiomyocytes (see below). (Figures 5 and 6 ). This observation provides independent evidence that the degree of inhibition is determined by NCX IF dose and not by [Ca 2+ ] i . As a precaution, one has to take into account that under the experimental conditions tested here, the regulatory sites of NCX1 are fully saturated with cytosolic Ca 2+ . Therefore, a more extensive investigation is required for testing the effects of NCX IF on the interaction of Ca 2+ with the CBD1 and CBD2 domains.
DISCUSSION
Purification procedures developed in our laboratory (17, 18) permitted primary characterization of NCX IF properties (17) (18) (19) (20) (21) (22) (23) , although these preparations still suffer from weak chromatographic resolution, inadequate pure loading capacity, and low yield. Since milligram quantities of purified NCX IF are required for structural studies, here we describe further improvements in the purification procedures. Although our previous work provided accumulating evidence for the NCX IF -induced inhibition of NCX1 activities in vitro (17) (18) (19) and for the modulation of muscle contractility (17, (20) (21) (22) (23) , there was no evidence for inhibition of NCX1 in the singlecell system. Therefore, this work represents the first attempt at measuring the direct actions of NCX IF on the Na modes of NCX1 (Figure 3 ). It appears that NCX IF acts effectively from the cytosolic side ( Figures 5 and 6) , exhibiting an inhibitory potency that is comparable with the inhibitory potency observed previously with in vitro systems of isolated sarcolemma vesicles (17) (18) (19) (20) (Figure 1) . Despite a significant improvement in preparative procedures, the available amounts of purified NCX IF are still not sufficient for elucidation of the NCX IF structure by twodimensional NMR. To obtain sufficient (milligram) quantities of NCX IF for structural analysis by NMR, one has to scale up the existing purification procedures at least 5-10-fold (with starting material of 40-50 kg ventricles). Unfortunately, these near-industrial procedures for purification could not be handled in this work due to the lack of available resources.
Another principal problem in molecular identification of NCX IF is that the de novo identification of unknown substances by MS techniques depends on the chemical nature of the investigated substance (39, 40) . For example, small charged molecules (e.g., such as peptides) can be successfully analyzed even at 10 -9 M, whereas the analysis of hydrophilic, uncharged molecules (e.g., such as small polyols) could be a challenge even at 10 -3 M (39-41). If NCX IF is a hydroxylrich compound (as we suspect), this would explain why it is so difficult to resolve its structure by MS techniques. Consistent with our previous findings (18) , NCX IF exhibits very weak absorption only in the short-UV (190-200 nm) range (Figure 2 ), thereby suggesting that neither aromatic rings (nucleotides, phenols, indols, etc.) nor conjugated chemical groups are present. In agreement with previous analyses (17, 18) , purified NCX IF (Figure 2 ) does not react with fluorescamine or phenol-sulfur reagents. Therefore, there is no evidence that NCX IF contains primary amine or aldehyde groups. In potential, the covalent modification of putative hydroxyl groups of NCX IF may enhance the MS and/or NMR signals by 1 order of magnitude, but unfortunately, due to the extremely low solubility of NCX IF in organic solvents (even in pyridine), the chemical modification of hydroxyl group(s) is also not a trivial task.
NCX IF (33, 38) , this explanation is unsatisfactory (42) , given the requirements of thermodynamics (50, 51) . This may be explained by the fact that experimental conditions are not sufficiently comparable in the KB-R7943 studies. Here, the conditions for examining both modes of NCX1 action were nearly identical when NCX IF was used to block NCX1. NCX IF blocks equally well for both the Ca 2+ entry and Ca 2+ exit modes of NCX1, as shown in Figure 3 . Moreover, NCX IF alters not only the rates of Ca 2+ entry and exit modes but also the rate constants of both modes ( Figure  3B ). These data suggest that NCX IF may alter the turnover rate constant of the exchange cycle by affecting the ratelimiting step of net ion transport. This is in a good agreement with previous results (21) , suggesting that NCX IF affects the rate-limiting step of ion translocation without interfering with ion binding at the transport site(s) of NCX1. (Figures 5 and 6) , suggesting that the extent of inhibition is controlled by NCX IF dose and not by cytosolic Ca 2+ level. The significance of these findings is that NCX IF may interact with some specific cytosolic domain to inhibit NCX1. Notably, the regulatory sites of NCX1 are fully saturated by cytosolic Ca 2+ under the experimental conditions tested here (Figures 5 and 6) . Therefore, the future testing of NCX IF for its capacity to affect the interactions of Ca 2+ with the CBD1 and CBD2 domains is highly encouraging.
These experiments clearly demonstrate that NCX IF can be effectively "entrapped" inside the cell by direct loading of NCX IF into the cytoplasm of patched cardiomyocyte ( Figures  4-6 ). Although unproven, it seems plausible that an extracellular site of action is unlikely since the extracellular concentration would be significantly reduced by dilution following intracellular administration. In contrast, the extracellular application of NCX IF would tend to load the cell with the inhibitor if it should leak (transport) in, as we suspect it does. This would then explain the efficacy of extracellular application of NCX IF in these experiments describing the bidirectional inhibition of NCX1 (Figure 3 ). In the absence of NCX IF breakdown, extracellular application of NCX IF should lead to steady-state levels of intracellular NCX IF approaching the extracellular concentration.
Brief Comparison of NCX IF with Existing NCX Blockers.
A considerable amount of work has been devoted to the development of peptide (27) (28) (29) (30) (31) (32) (42) (43) (44) and organic (38, (45) (46) (47) NCX blockers; however, all of them have some specific but principal drawbacks. For example, the synthetic blockers (KB-R7943, SEA-0400, and SN-6) inhibit not only NCX but also the other ion transport systems (38, 48) . Another principal drawback is the enigmatic putative preferential inhibition of the Ca 2+ entry mode, which would appear to limit its pharmacological significance and utility (33, 49) . In contrast to the organic NCX blockers, XIP and FRCRCFa can effectively inhibit both the inward and outward currents of NCX by interacting with the cytosolic domain (42) (43) (44) , but these blockers are inactive when added extracellularly due to their impermeability to the cell membrane.
In contrast to the synthetic blocker, KB-R7943, NCX IF results in a comparable inhibition of both the Ca 2+ entry and Ca 2+ exit modes in intact cardiomyocytes (Figure 3) . Although KB-R7943 and NCX IF are both active when added outside the cell, the striking difference is that KB-R7943 interacts with the extracellular domain, whereas NCX IF might approach the cytosolic site to inhibit NCX1 (Figures 5 and  6 ). More extensive research is required for comparing NCX IF with the more recently developed NCX inhibitors, SEA0400 and SN-6.
